results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
Page 1 of 2 AC6305/006 May 14, 2020 Subject Clarification of the operating results for the quarter 1/2020 ended March 31, 2020 To Director/ Managing Director The Stock Exchange of Thailand According
according to the target of purchase from major suppliers in 2020. Cost of equipment for lease increased by 52.6%. This is because some projects of equipment for lease were renewed by a shorter contract term
product design and development. Thus, the Company will continue to seek more partnership both inside and outside the food industry, in response to consumer behavior according to the New Normal lifestyle and
from the decline in operating revenue due to the impact from the new COVID-19 wave, as well as the temporary closure of some dessert cafe branches according to the government measures. • The Company’s
for diminishing value of inventories (NRV) as of December 31, 2019. There is no allowance for diminishing value of inventories (NRV) as of December 31, 2021. Summary according to the following segments
Company’s cost of sales to total revenue ratio was increased by 7.70% as compared to the same period of last year, according to the raise the price of domestic palm oil. Although, the Company still maintains
Foreign Auditors in the Capital Market according to the (select only one that apply) Clause 6(1) of the Notification of the Office of the Securities and Exchange Commission No. SorShor 30/2558 Re: Approval
customer’s order according to rules prescribed in this Notification; or (2) sale of securities pursuant to the customer’s order where the customer has not yet delivered possession of such securities to the